Skip to main content
Ardeshir Rastinehad, DO, Urology, New York, NY, Lenox Hill Hospital

ArdeshirRustomRastinehadDOFACOS

Urology • New York, NY

Minimally Invasive Surgery, Stone Disease, Surgical Oncology

Vice Chair at the Smith Institute for Urology at Lenox Hill Hospital, System Director for Prostate Cancer at Northwell Health.

Join to view full profile

Dr. Rastinehad is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Rastinehad's full profile

Already have an account?

Summary

  • Northwell Health’s System Director for Prostate Cancer at the Cancer Institute
    Vice Chair at the Smith Institute for Urology at Lenox Hill Hospital
    Art Rastinehad, D.O. joined the faculty at Northwell Health in January 2020. He is the Northwell Health’s System Director for Prostate Cancer at the Cancer Institute and the Vice Chair of Urology at Lenox Hill Hospital. He trained at the National Cancer Institute as an Interventional Urologic Oncologist and is the first urologist to be dual fellowship trained in Urologic Oncology and Interventional Radiology. He has expertise in a wide array of interventional radiological and surgical techniques, including image guided procedures, prostate artery embolization, laparoscopic and robotic surgery.
    Dr. Rastinehad’s prostate cancer team has now incorporated state-of-the-art imaging to help visualize suspicious areas in the prostate for cancer. Dr. Rastinehad has also authored and implemented clinical trials of new techniques in the diagnosis and treatment of localized prostate cancer. In 2011 at Northwell Heath, he was the principal investigator for a Phase III clinical trial using MRI/Ultrasound fusion technology to improve prostate biopsy techniques. Using information from the prostate MRI, we can now target specific areas to better diagnose and quantify a patient’s prostate cancer. This was the first trial of this technology in the United States outside the National Institutes of Health.
    This new clinical approach is helping to lay a foundation for the evaluation of a new technique, Focal Therapy, which only treats the diseased portion of the prostate. As of May 2016, Dr Rastinehad was the first in the world to perform a gold nano-particle directed ablation using an transperineal MR US Fusion guided focal therapy system. Dr Rastinehad and his team recently published the first series using this new technology in Proceedings of the National Academy of Science (PNAS).

Education & Training

  • National Institutes of Health Clinical Center
    National Institutes of Health Clinical CenterFellowship, Minimally Invasive Urologic Surgery, 2009 - 2011
  • Zucker School of Medicine at Hofstra/Northwell
    Zucker School of Medicine at Hofstra/NorthwellResidency, Urology, 2004 - 2009
  • Zucker School of Medicine at Hofstra/Northwell
    Zucker School of Medicine at Hofstra/NorthwellFellowship, Vascular and Interventional Radiology, 2008 - 2008
  • NYIT College Of Osteopathic Medicine
    NYIT College Of Osteopathic MedicineClass of 2004
  • Rochester Institute of Technology
    Rochester Institute of TechnologyB.S., Biochemistry, 1993 - 1997

Certifications & Licensure

  • NY State Medical License
    NY State License 2007 - 2025
  • MD State Medical License
    MD State License 2010 - 2011
  • American Board of Urology Urology

Awards, Honors, & Recognition

  • The Arthur Smith Award for Innovation Endourological Society, 2021
  • Young Urologists of the Year American Urological Association, 2019
  • Best Paper Award Engineering and Urology Society, AUA (American Urological Association), 2017
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Estimated Costs Associated with Radiation Therapy for Positive Surgical Margins During Radical Prostatectomy  
    Ashutosh K Tewari, Ardeshir R Rastinehad, JAMA Network Open
  • Implementation of Multiparametric Magnetic Resonance Imaging Technology for Evaluation of Patients with Suspicion for Prostate Cancer in the Clinical Practice Setting  
    Shah PH, Patel VR, Moreira DM, George AK, Alom M, Kozel Z, Joshi V, Ben-Levi E, Villani R, Yaskiv O, Kavoussi LR, Vira M, Olsson CO, Rastinehad AR, BJU Int, 1/16/2018
  • Targeted Ablative Therapies for Prostate Cancer  
    Winoker JS, Anastos H, Rastinehad AR, Cancer Treat Res, 1/1/2018
  • Join now to see all

Books/Book Chapters

  • The Fundementals of Image-Guided Surgery 
    Chapter: Interventional Urology 
    Arvin K Geroge, John Michael DiBianco, Ardeshir RastinehadSpringer2015
  • Campbells-Walsh Urology 
    Chapter: Urinary Tract Imaging: Basic Principals 
    Jay Bishoff MD and Art Rasitnehad D.O.Edition 12th,2014
  • Smith's Text Book of Endourology 
    Chapter: Angioembolization in Urology 
    Rastinehad AR, Pinto PA, Siegel DNEdition 3rd,2011
  • Join now to see all

Abstracts/Posters

  • V12-11 Mr/Transperineal Ultrasound Fusion-Guided Prostate Biopsy In The Patient Without Anus.
    Lauren E Corona, Robert S. Wang, Matthew Davenport, Nicole Curci, Ardeshir R. Rastinehad, Christof Kastner, Arvin K. George, The Journal of Urology, AUA (American Urological Association), 1/1/2018
  • Mp26-10 Magnetic Resonance Imaging Guided Focal Laser Therapy Of Prostate Cancer: Follow Up Results From A Single Center Phase I Trial.
    Sherif Mehralivand, Arvin George, Anthony Hoang, Soroush Rais-Bahrami, Ardeshir Rastinehad, Vladimir Valera Romero, Jonathan Bloom, Samuel Gold, The Journal of Urology, AUA (American Urological Association), 1/1/2018
  • Mp14-17 Role Of Magnetic Resonance Imaging In Predicting Adverse Pathology Post-Radical Prostatectomy.
    Alp Tuna Beksac, Ugo Falagario, Shivaram Cumarasamy, Akriti Gupta, Paige Xu, Sonya Prasad, Alberto Martini, Hari Thulasidass, The Journal of Urology, AUA (American Urological Association), 1/1/2018
  • Join now to see all

Lectures

  • Interventional Urology 
    1/31/2018
  • Focal Therapy and GSN directed ablation. 
    1/20/2018
  • MRI to Avoid of Biopsies 
    1/1/2018
  • Join now to see all

Other

  • Prostate Cancer Screening: MR US Fusion Guided Biopsy 
    Rastinehad AR, Focus on Health, TV Channel 55 (10:30 am)
    New York City - 1/11/2014
  • The Prostate Fusion Biopsy Program 
    Rastinehad AR, Fox 5 News
    http://www.foxnews.com/health/2013/04/09/new-prostate-cancer-technology-could-lead-to-more-targeted-therapies/
    1/10/2013
  • New Prostate Tumor Technology Called Equivalent Of GPS 
    Rastinehad AR, Newsday
    1/2/2013
  • Join now to see all

Authored Content

  • Estimated Costs Associated with Radiation Therapy for Positive Surgical Margins During Radical ProstatectomyMarch 2020
  • New Focal Therapy Advances in NanoMedicine for Prostate CancerAugust 2019
  • Fusion Prostate Biopsy Outperforms 12-Core Systematic Prostate Biopsy in Patients with Prior Negative Systematic Biopsy: A Multi-Institutional AnalysisMay 2018

Press Mentions

  • How ‘90210’ Star Brian Austin Green Learned to Manage His Ulcerative Colitis
    How ‘90210’ Star Brian Austin Green Learned to Manage His Ulcerative ColitisSeptember 14th, 2022
  • Special Gold Shows Promise as Effective Treatment for Prostate Cancer
    Special Gold Shows Promise as Effective Treatment for Prostate CancerAugust 28th, 2019
  • Quest for New Cancer Treatment Crosses Milestone
    Quest for New Cancer Treatment Crosses MilestoneAugust 26th, 2019
  • Join now to see all

Professional Memberships

Hospital Affiliations

External Links

  • Art Rastinehadhttp://www.interventionalurology.com
  • Fusion Biopsyhttp://www.fusion-biopsy.com
  • Youtubehttps://www.youtube.com/channel/UCdktfeNDUCbomi3ww0gxCgg?view_as=subscriber

Dr. Ardeshir Rastinehad, Dr. Ardeshir Rastinehad, DO, Dr. A Rastinehad, Dr. Ardeshir Rustom Rastinehad